Distinct prevalence of antibodies to the E2 protein of GB virus C/hepatitis G virus in different parts of the world

Since the identification of the new human virus, GB virus C (GBV‐C)/hepatitis G virus (HGV), in 1995/1996, reverse transcription polymerase chain reaction remained the sole available diagnostic tool for GBV‐C/HGV infection. Recently, a serologic test based on the detection of antibodies to the putat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of medical virology 1998-02, Vol.54 (2), p.103-106
Hauptverfasser: Ross, R. S., Viazov, S., Schmitt, U., Schmolke, S., Tacke, M., Ofenloch-Haehnle, B., Holtmann, M., Müller, N., Da Villa, G., Yoshida, C. F., Oliveira, J. M., Szabo, A., Paladi, N., Kruppenbacher, J. P., Philipp, Th, Roggendorf, M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Since the identification of the new human virus, GB virus C (GBV‐C)/hepatitis G virus (HGV), in 1995/1996, reverse transcription polymerase chain reaction remained the sole available diagnostic tool for GBV‐C/HGV infection. Recently, a serologic test based on the detection of antibodies to the putative envelope protein 2 (anti‐E2) has been introduced. We used this assay for a seroepidemiological survey including 3,314 healthy individuals from different parts of the world, 123 patients from Germany who were suspected to have an increased risk of acquiring GBV‐C/HGV infection, 128 multiple organ donors, and 90 GBV‐C/HGV RNA positive persons. In European countries, anti‐E2 seropositivity ranged from 10.9% (Germany) to 15.3% (Austria). In South Africa (20.3%) and Brazil (19.5%), even higher anti‐E2 prevalence rates were recorded. In Asian countries like Bhutan (3.9%), Malaysia (6.3%), and the Philippines (2.7%), anti‐E2 positivity was significantly lower. GBV‐C/HGV anti‐E2 prevalence in potential “risk groups,” i.e., patients on hemodialysis and renal transplant recipients, did not vary significantly from anti‐E2 seroprevalence in German blood donors. Anti‐E2 and GBV‐C/HGV RNA were found to be mutually exclusive, confirming the notion that anti‐E2 has to be considered as a marker of past infection. J. Med. Virol. 54:103–106, 1998. © 1998 Wiley‐Liss,Inc.
ISSN:0146-6615
1096-9071
DOI:10.1002/(SICI)1096-9071(199802)54:2<103::AID-JMV6>3.0.CO;2-A